CELLINBIO CO., LTD;CATHOLIC UNIVERSITY INDUSTRY ACADEMIC COOPERATION FOUNDATION
发明人:
Nam Jae-Hwan,Park Hye-Lim,Lee Dong-Hee
申请号：
US201414784614
公开号：
US9737588(B2)
申请日:
2014.04.16
申请国别(地区):
美国
年份:
2017
代理人:
Faegre Baker Daniels LLP
摘要：
The present invention relates to a pharmaceutical composition for treating and/or preventing arthritis, which comprising, as an active ingredient, a gene delivery vehicle into which an IK factor or a fragment thereof, or a nucleic acid encoding thereof is inserted. IK factor or the fragment thereof, and the nucleic acid encoding thereof, which are the active ingredient of the pharmaceutical composition according to the present invention, are derived from an organism and therefore, show no side effects in administered into a subject for a long time. Accordingly, they ensures safety and are expected to effectively treat arthritis by being involved in the upstream mechanism for suppressing arthritis.
